Within the past 5 years, vancomycin-resistant enterococci (VRE) have swept throughout the US and Europe. Many of these organisms are also highly resistant to β-lactams and aminoglycosides, thereby making them virtually unbeatable. Optimal therapy for these infections is unknown despite extremely high mortality rates for patients with VRE bacteremia. Until effective therapy is available, prevention of transmission by adequate infection control procedures and judicious antibiotic use is critical.
|Original language||English (US)|
|Journal||Infections in Medicine|
|State||Published - Jun 1 1996|
- Drug resistance
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases